oral glp 1 agonist GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients | Cardiovascular Diabetology GLP-1 receptor agonist - Diabetes
Description
J Neuroinflammation
Abstract Type 2 diabetes mellitus (T2DM) and obesity are metabolic disorders characterized by excess cardiovascular risk
These typically resolve within 8 to 24 hours but can lead to clinically significant complications, including dehydration, acute kidney injury, and electrolyte abnormalities
4mg weekly dose At 4mg, the weight loss curve steepens dramatically
Apples are a good source of pectin, which is a good source of soluble fiber
